IL-1β Upregulates IL-8 Production in Human Müller Cells Through Activation of the p38 MAPK and ERK1/2 Signaling Pathways

Inflammation

Volumn 37, Issue 5, 2014, Pages 1486-1495

  Liu, Xiufen ^a   Ye, Fei ^b   Xiong, Huabao ^b   Hu, Danning ^c   Limb, G Astrid ^d   Xie, Tian ^e   Peng, Liang ^b   Yang, Wei ^a   Sun, Yabin ^a   Zhou, Mingming ^b   Song, E ^a   Zhang, David Y ^b  

^a JILIN UNIVERSITY   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NEW YORK EYE AND EAR INFIRMARY   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e People's Hospital of Jilin Province   (China)

Author keywords

cytokines; diabetic retinopathy; ERK1 2; IL 1 ; IL 8; M ller cells; p38 MAPK

Indexed keywords

GAMMA INTERFERON; GLUCOSE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE 2; MANNITOL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MUELLER CELL; POLYMERASE CHAIN REACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; ENZYME ACTIVATION; MACROGLIA; METABOLISM; PHYSIOLOGY;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EPENDYMOGLIAL CELLS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; UP-REGULATION;

EID: 84918836866     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9874-5     Document Type: Article

References (56)

1. Schroder, S., W. Palinski, and G.W. Schmid-Schonbein. 1991. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. The American Journal of Pathology 139: 81–100.
2. Mackinnon, J.R., R.M. Knott, and J.V. Forrester. 2004. Altered L-selectin expression in lymphocytes and increased adhesion to endothelium in patients with diabetic retinopathy. British Journal of Ophthalmology 88: 1137–1141.
3. Yuuki, T., T. Kanda, Y. Kimura, N. Kotajima, J. Tamura, I. Kobayashi, and S. Kishi. 2001. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. Journal of Diabetic Complications 15: 257–259.
4. El-Asrar, A.M., M.I. Nawaz, D. Kangave, K. Geboes, M.S. Ola, S. Ahmad, and M. Al-Shabrawey. 2011. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. Molecular Vision 17: 1829–1838.
5. Demircan, N., B.G. Safran, M. Soylu, A.A. Ozcan, and S. Sizmaz. 2006. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye (London, England) 20: 1366–1369.
6. Scuderi, S., A.G. D'amico, A. Castorina, R. Imbesi, M.L. Carnazza, and V. D'agata. 2013. Ameliorative effect of PACAP and VIP against increased permeability in a model of outer blood retinal barrier dysfunction. Peptides 39: 119–124.
7. Liu, Y., M. Biarnes Costa, and C. Gerhardinger. 2012. IL-1beta is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1beta autostimulation. PLoS One 7: e36949.
8. Agrawal, S.S., S. Naqvi, S.K. Gupta, and S. Srivastava. 2012. Prevention and management of diabetic retinopathy in STZ diabetic rats by Tinospora cordifolia and its molecular mechanisms. Food and Chemical Toxicology 50: 3126–3132.
9. Krady, J.K., A. Basu, C.M. Allen, Y. Xu, K.F. Lanoue, T.W. Gardner, and S.W. Levison. 2005. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54: 1559–1565.
10. Shen, X., B. Xie, Y. Cheng, Q. Jiao, and Y. Zhong. 2011. Effect of pigment epithelium derived factor on the expression of glutamine synthetase in early phase of experimental diabetic retinopathy. Ocular Immunology and Inflammation 19: 246–254.
11. Zhang, Y., G. Xu, Q. Ling, and C. Da. 2011. Expression of aquaporin 4 and Kir4.1 in diabetic rat retina: treatment with minocycline. Journal of International Medical Research 39: 464–479.
12. Gustavsson, C., C.D. Agardh, P. Hagert, and E. Agardh. 2008. Inflammatory markers in nondiabetic and diabetic rat retinas exposed to ischemia followed by reperfusion. Retina 28: 645–652.
13. El-Ghrably, I.A., H.S. Dua, G.M. Orr, D. Fischer, and P.J. Tighe. 2001. Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy. British Journal of Ophthalmology 85: 461–470.
14. Dong, N., B. Xu, B. Wang, and L. Chu. 2013. Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy. Molecular Vision 19: 1734–1746.
15. Suzuki, Y., M. Nakazawa, K. Suzuki, H. Yamazaki, and Y. Miyagawa. 2011. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Japanese Journal of Ophthalmology 55: 256–263.
16. Zhou, J., S. Wang, and X. Xia. 2012. Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy. Current Eye Research 37: 416–420.
17. Johnsen-Soriano, S., M. Sancho-Tello, E. Arnal, A. Navea, E. Cervera, F. Bosch-Morell, M. Miranda, and F. Javier Romero. 2010. IL-2 and IFN-gamma in the retina of diabetic rats. Graefe's Archive for Clinical and Experimental Ophthalmology 248: 985–990.
18. Kawashima, M., J. Shoji, Y. Kamura, and Y. Sato. 2005. Role of chemokines in the vitreous of proliferative diabetic retinopathy. Nihon Ganka Gakkai Zasshi 109: 596–602.
19. Baggiolini, M., and I. Clark-Lewis. 1992. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Letters 307: 97–101.
20. Jorens, P.G., J.B. Richman-Eisenstat, B.P. Housset, P.D. Graf, I.F. Ueki, J. Olesch, and J.A. Nadel. 1992. Interleukin-8 induces neutrophil accumulation but not protease secretion in the canine trachea. American Journal of Physiology 263: L708–L713.
21. Srinivasan, S., M. Yeh, E.C. Danziger, M.E. Hatley, A.E. Riggan, N. Leitinger, J.A. Berliner, and C.C. Hedrick. 2003. Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circulation Research 92: 371–377.
22. Gesser, B., M. Lund, N. Lohse, C. Vestergaad, K. Matsushima, S. Sindet-Pedersen, S.L. Jensen, K. Thestrup-Pedersen, and C.G. Larsen. 1996. IL-8 induces T cell chemotaxis, suppresses IL-4, and up-regulates IL-8 production by CD4+ T cells. Journal of Leukocyte Biology 59: 407–411.
23. Koch, A.E., P.J. Polverini, S.L. Kunkel, L.A. Harlow, L.A. Dipietro, V.M. Elner, S.G. Elner, and R.M. Strieter. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798–1801.
24. Koskela, U.E., S.M. Kuusisto, A.E. Nissinen, M.J. Savolainen, and M.J. Liinamaa. 2013. High vitreous concentration of IL-6 and IL-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy. Ophthalmic Research 49: 108–114.
25. Arjamaa, O., M. Pollonen, K. Kinnunen, T. Ryhanen, and K. Kaarniranta. 2011. Increased IL-6 levels are not related to NF-kappaB or HIF-1alpha transcription factors activity in the vitreous of proliferative diabetic retinopathy. Journal of Diabetes and its Complications 25: 393–397.
26. Lange, C.A., P. Stavrakas, U.F. Luhmann, D.J. De Silva, R.R. Ali, Z.J. Gregor, and J.W. Bainbridge. 2011. Intraocular oxygen distribution in advanced proliferative diabetic retinopathy. The American Journal of Pathology 152(406–412): e403.
27. Wakabayashi, Y., Y. Usui, Y. Okunuki, T. Kezuka, M. Takeuchi, T. Iwasaki, A. Ohno, and H. Goto. 2011. Increases of vitreous monocyte chemotactic protein 1 and interleukin 8 levels in patients with concurrent hypertension and diabetic retinopathy. Retina 31: 1951–1957.
28. Wakabayashi, Y., Y. Usui, Y. Okunuki, T. Kezuka, M. Takeuchi, H. Goto, and T. Iwasaki. 2010. Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy. Retina 30: 339–344.
29. Yoshimura, T., K.H. Sonoda, M. Sugahara, Y. Mochizuki, H. Enaida, Y. Oshima, A. Ueno, Y. Hata, H. Yoshida, and T. Ishibashi. 2009. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One 4: e8158.
30. Murugeswari, P., D. Shukla, A. Rajendran, R. Kim, P. Namperumalsamy, and V. Muthukkaruppan. 2008. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales’ disease. Retina 28: 817–824.
31. Canataroglu, H., I. Varinli, A.A. Ozcan, A. Canataroglu, F. Doran, and S. Varinli. 2005. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy. Ocular Immunology and Inflammation 13: 375–381.
32. Hernandez, C., R.M. Segura, A. Fonollosa, E. Carrasco, G. Francisco, and R. Simo. 2005. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy. Diabetic Medicine 22: 719–722.
33. Cicik, E., H. Tekin, S. Akar, O.B. Ekmekci, O. Donma, L. Koldas, and S. Ozkan. 2003. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Ophthalmic Research 35: 251–255.
34. Nicoletti, R., I. Venza, G. Ceci, M. Visalli, D. Teti, and A. Reibaldi. 2003. Vitreous polyamines spermidine, putrescine, and spermine in human proliferative disorders of the retina. British Journal of Ophthalmology 87: 1038–1042.
35. Lee, W.J., M.H. Kang, M. Seong, and H.Y. Cho. 2012. Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion. British Journal of Ophthalmology 96: 1426–1430.
36. Funk, M., G. Schmidinger, N. Maar, M. Bolz, T. Benesch, G.J. Zlabinger, and U.M. Schmidt-Erfurth. 2010. Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Retina 30: 1412–1419.
37. Jonas, J.B., R.A. Jonas, M. Neumaier, and P. Findeisen. 2012. Cytokine concentration in aqueous humor of eyes with diabetic macular edema. Retina 32: 2150–2157.
38. Lopez, P.F., H.E. Grossniklaus, H.M. Lambert, T.M. Aaberg, A. Capone Jr., P. Sternberg Jr., and N. L'hernault. 1991. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. The American Journal of Pathology 112: 647–656.
39. Roh, M.I., H.S. Kim, J.H. Song, J.B. Lim, H.J. Koh, and O.W. Kwon. 2009. Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with amd after bevacizumab treatment. Retina 29: 523–529.
40. Ahmad, I., C.B. Del Debbio, A.V. Das, and S. Parameswaran. 2011. Muller glia: a promising target for therapeutic regeneration. Investigative Ophthalmology & Visual Science 52: 5758–5764.
41. Newman, E., and A. Reichenbach. 1996. The Muller cell: a functional element of the retina. Trends in Neurosciences 19: 307–312.
42. Zhong, Y., J. Li, Y. Chen, J.J. Wang, R. Ratan, and S.X. Zhang. 2012. Activation of endoplasmic reticulum stress by hyperglycemia is essential for Muller cell-derived inflammatory cytokine production in diabetes. Diabetes 61: 492–504.
43. Mizutani, M., C. Gerhardinger, and M. Lorenzi. 1998. Muller cell changes in human diabetic retinopathy. Diabetes 47: 445–449.
44. Takeda, M., A. Takamiya, A. Yoshida, and H. Kiyama. 2002. Extracellular signal-regulated kinase activation predominantly in Muller cells of retina with endotoxin-induced uveitis. Investigative Ophthalmology & Visual Science 43: 907–911.
45. Walker, R.J., and J.J. Steinle. 2007. Role of beta-adrenergic receptors in inflammatory marker expression in Muller cells. Investigative Ophthalmology & Visual Science 48: 5276–5281.
46. Goczalik, I., E. Ulbricht, M. Hollborn, M. Raap, S. Uhlmann, M. Weick, T. Pannicke, P. Wiedemann, A. Bringmann, A. Reichenbach, and M. Francke. 2008. Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina. Investigative Ophthalmology & Visual Science 49: 4578–4589.
47. Limb, G.A., T.E. Salt, P.M. Munro, S.E. Moss, and P.T. Khaw. 2002. In vitro characterization of a spontaneously immortalized human Muller cell line (MIO-M1). Investigative Ophthalmology & Visual Science 43: 864–869.
48. Lei, X., J. Zhang, J. Shen, L.M. Hu, Y. Wu, L. Mou, G. Xu, W. Li, and G.T. Xu. 2011. EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy. Frontiers in Bioscience (Elite edition) 3: 201–211.
49. Dinarello, C.A. 1996. Biologic basis for interleukin-1 in disease. Blood 87: 2095–2147.
50. Rothwell, N.J., and G.N. Luheshi. 2000. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends in Neurosciences 23: 618–625.
51. Kowluru, R.A., and S. Odenbach. 2004. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. British Journal of Ophthalmology 88: 1343–1347.
52. Kumar, A., and N. Shamsuddin. 2012. Retinal Muller glia initiate innate response to infectious stimuli via toll-like receptor signaling. PLoS One 7: e29830.
53. Bian, Z.M., S.G. Elner, A. Yoshida, S.L. Kunkel, J. Su, and V.M. Elner. 2001. Activation of p38, ERK1/2 and NIK pathways is required for IL-1beta and TNF-alpha-induced chemokine expression in human retinal pigment epithelial cells. Experimental Eye Research 73: 111–121.
54. Shamsuddin, N., and A. Kumar. 2011. TLR2 mediates the innate response of retinal Muller glia to Staphylococcus aureus. The Journal of Immunology 186: 7089–7097.
55. Vij, N., A. Sharma, M. Thakkar, S. Sinha, and R.R. Mohan. 2008. PDGF-driven proliferation, migration, and IL8 chemokine secretion in human corneal fibroblasts involve JAK2-STAT3 signaling pathway. Molecular Vision 14: 1020–1027.
56. Cheranov, S.Y., D. Wang, V. Kundumani-Sridharan, M. Karpurapu, Q. Zhang, K.R. Chava, and G.N. Rao. 2009. The 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires Janus kinase 2-signal transducer and activator of transcription-5B-dependent expression of interleukin-8. Blood 113: 6023–6033.